Sign In
Buy DVA
$195.03
+7.14 (+3.80%)
At Close: Jun 03, 2026
The Final Peak Week Of The Q2 Season Begins Amid Souring Economic Data
03:20am, Tuesday, 06'th Aug 2024
This marks the last peak week of the Q2 earnings season with 3,908 companies expected to report. Earnings have come in better-than-expected, but tend to be overshadowed by economic data. Outlier earni
Strength in Kidney Care Likely to Aid DaVita's (DVA) Q2 Earnings
12:41pm, Monday, 05'th Aug 2024
Improvement in RPT and cost-saving initiatives are likely to have boosted DaVita's (DVA) top line in the second quarter.
4 Stocks to Watch From a Challenging Outpatient Home Health Industry
11:41am, Wednesday, 31'st Jul 2024
Despite the macroeconomic challenges, dependence on telehealth and AI dominance are likely to drive the Zacks Medical - Outpatient and Home Healthcare industry. DGX, DVA, EHC and ADUS are well-poised
DaVita HealthCare (DVA) Suffers a Larger Drop Than the General Market: Key Insights
07:01pm, Tuesday, 30'th Jul 2024
In the latest trading session, DaVita HealthCare (DVA) closed at $136.47, marking a -1.93% move from the previous day.
2 Warren Buffett small-cap stocks to turn $100 into $1000 by 2025
05:46am, Monday, 29'th Jul 2024
As the second half of 2024 unfolds, the stock market continues to offer various investment opportunities ranging from large to small-cap equities.
DaVita HealthCare (DVA) Laps the Stock Market: Here's Why
07:21pm, Monday, 22'nd Jul 2024
The latest trading day saw DaVita HealthCare (DVA) settling at $139.96, representing a +1.46% change from its previous close.
DaVita Inc. Schedules 2nd Quarter 2024 Investor Conference Call
02:00pm, Thursday, 18'th Jul 2024
DENVER , July 18, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA), announced today that it will hold its quarterly conference call to discuss second quarter results on Tuesday, August 6, 2024, at 5:00
DaVita HealthCare (DVA) Rises Higher Than Market: Key Facts
07:05pm, Tuesday, 16'th Jul 2024
DaVita HealthCare (DVA) reachead $137.72 at the closing of the latest trading day, reflecting a +1.3% change compared to its last close.
DaVita (DVA) Gains 29.8% YTD: What's Driving the Stock?
01:16pm, Tuesday, 16'th Jul 2024
DaVita's (DVA) shares gain on the back of strong fundamentals. However, dependence on commercial payers can be a cause of concern.
Renal Denervation Devices Market Size, Share & Trends Analysis Report By Technology (Radiofrequency-based, Ultrasound-based, Micro-infusion-based, Others), By End User (Hospitals & Clinics, Ambulatory
US FTC probing DaVita, Fresenius Medical, Politico reports
09:16am, Saturday, 13'th Jul 2024
The U.S. Federal Trade Commission (FTC) is investigating healthcare providers DaVita and Fresenius Medical Care over allegations that the companies have been illegally thwarting smaller competitors, P
Here's Why You Should Add DaVita (DVA) to Your Portfolio
07:11am, Friday, 12'th Jul 2024
DaVita's (DVA) strength in its kidney care raises optimism about the stock.
Here's Why DaVita HealthCare (DVA) is a Strong Value Stock
10:41am, Wednesday, 10'th Jul 2024
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
DaVita HealthCare (DVA) Surpasses Market Returns: Some Facts Worth Knowing
07:20pm, Tuesday, 09'th Jul 2024
DaVita HealthCare (DVA) concluded the recent trading session at $137.92, signifying a +0.39% move from its prior day's close.
Here's Why You Should Add DaVita (DVA) to Your Portfolio Now
08:30am, Thursday, 04'th Jul 2024
DaVita's (DVA) strength in its kidney care segment raises optimism about the stock.
